BENZOTHIAZYL DISULFIDE
| SMILES | c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 |
| InChIKey | AFZSMODLJJCVPP-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 0 |
| Rotatable bonds | 3 |
| Molecular weight (Da) | 332.0 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| MC5 | MC5R | Human | Melanocortin | A | pKi | 5.43 | 5.43 | 5.43 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.13 | 7.13 | 7.13 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.62 | 6.62 | 6.62 | ChEMBL |
| CCR2 | CCR2 | Human | Chemokine | A | pKi | 6.03 | 6.03 | 6.03 | ChEMBL |
| 5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 6.37 | 6.37 | 6.37 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 6.47 | 6.47 | 6.47 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pKi | 6.22 | 6.22 | 6.22 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 5.61 | 5.61 | 5.61 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 6.54 | 6.54 | 6.54 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pKi | 6.71 | 6.71 | 6.71 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.3 | 6.3 | 6.3 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 5.9 | 5.9 | 5.9 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pKi | 5.71 | 5.71 | 5.71 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| MC5 | MC5R | Human | Melanocortin | A | pIC50 | 5.41 | 5.41 | 5.41 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 6.79 | 6.79 | 6.79 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pIC50 | 5.78 | 5.78 | 5.78 | ChEMBL |
| CCR2 | CCR2 | Human | Chemokine | A | pIC50 | 5.62 | 5.62 | 5.62 | ChEMBL |
| 5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pIC50 | 6.13 | 6.13 | 6.13 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 6.05 | 6.05 | 6.05 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pIC50 | 5.92 | 5.92 | 5.92 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pIC50 | 5.28 | 5.28 | 5.28 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pIC50 | 6.07 | 6.07 | 6.07 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pIC50 | 6.46 | 6.46 | 6.46 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pIC50 | 5.91 | 5.91 | 5.91 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pIC50 | 5.51 | 5.51 | 5.51 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pIC50 | 5.23 | 5.23 | 5.23 | ChEMBL |